224 related articles for article (PubMed ID: 32523628)
1. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma.
Rouphael C; Anil Kumar M; Sanaka MR; Thota PN
Therap Adv Gastroenterol; 2020; 13():1756284820924209. PubMed ID: 32523628
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review.
Luigiano C; Iabichino G; Eusebi LH; Arena M; Consolo P; Morace C; Opocher E; Mangiavillano B
Gastroenterol Res Pract; 2016; 2016():4249510. PubMed ID: 28070182
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?
Singh T; Sanaka MR; Thota PN
World J Gastrointest Endosc; 2018 Sep; 10(9):165-174. PubMed ID: 30283599
[TBL] [Abstract][Full Text] [Related]
5. State-of-the-art management of dysplastic Barrett's esophagus.
Vantanasiri K; Iyer PG
Gastroenterol Rep (Oxf); 2022; 10():goac068. PubMed ID: 36381221
[TBL] [Abstract][Full Text] [Related]
6. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB; Washington K; Keswani RN
J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for Barrett's esophagus-related neoplasia.
Krajciova J; Vackova Z; Spicak J; Martinek J
Minerva Chir; 2018 Aug; 73(4):366-377. PubMed ID: 29806757
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
13. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
[TBL] [Abstract][Full Text] [Related]
14. Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions.
Konda VJ; Dalal K
Ther Clin Risk Manag; 2011; 7():447-58. PubMed ID: 22162921
[TBL] [Abstract][Full Text] [Related]
15. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
16. Management of Barrett's Esophagus.
Velanovich V
Am Surg; 2012 Nov; 78(11):1193-200. PubMed ID: 23089433
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic surveillance in Barrett's esophagus.
Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E
Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: Review of natural history and comparative efficacy of endoscopic and surgical therapies.
Choi KKH; Sanagapalli S
World J Gastrointest Oncol; 2022 Mar; 14(3):568-586. PubMed ID: 35321279
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic therapy for Barrett's oesophagus.
Blevins CH; Iyer PG
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):167-77. PubMed ID: 25743464
[TBL] [Abstract][Full Text] [Related]
20. Challenges with Endoscopic Therapy for Barrett's Esophagus.
Wani S; Sharma P
Gastroenterol Clin North Am; 2015 Jun; 44(2):355-72. PubMed ID: 26021199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
